Fluoxetine in adolescents with comorbid major depression and an alcohol use disorder a five-year follow-up study

Journal of Dual Diagnosis

Volumn 2, Issue 1, 2006, Pages 11-25

  Cornelius, Jack R ^a   Clark, Duncan B ^a   Bukstein, Oscar G ^a   Birmaher, Boris ^a   Kelly, Thomas M ^a   Salloum, Ihsan M ^a   Walters, Mary ^a   Matta, James ^a   Wood, D Scott ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Adolescents; Alcohol use disorder; Fluoxetine; Follow up; Major depression

Indexed keywords

ALCOHOL; CANNABIS; FLUOXETINE;

ACADEMIC ACHIEVEMENT; ADULT; ALCOHOL CONSUMPTION; ALCOHOLISM; ARTICLE; BECK DEPRESSION INVENTORY; BEHAVIOR THERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COURSE EVALUATION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG DEPENDENCE; DRUG TOLERABILITY; EVALUATION; FEMALE; FOLLOW UP; HUMAN; LONG TERM CARE; MAJOR DEPRESSION; MALE; MEDICAL ASSESSMENT; PATIENT COUNSELING; PSYCHOLOGIC ASSESSMENT; SUICIDAL IDEATION; SUICIDE ATTEMPT; SYMPTOM; THERAPY EFFECT; TREATMENT OUTCOME; TREATMENT RESPONSE;

EID: 33746904685     PISSN: 15504263     EISSN: 15504271     Source Type: Journal    
DOI: 10.1300/J374v02n01_03     Document Type: Article

References (31)

1. Bukstein OG, Glancy LJ, Kaminer Y. Patterns of affective comorbidity in a clinical population of dually diagnosed adolescent substance abusers. J Am Acad Child Adol Psychiatry 1992; 31:1041-1045.
2. Cornelius JR, Kirisci L, Clark DB. Major depression associated with AUD in large prospective study of adolescents. Alcohol Clin Exper Res 2004; 28:80A.
3. Clark DB, Wood DS, Cornelius JR, Bukstein OG, Martin CS. Clinical practices in the pharmacological treatment of comorbid psychopathology in adolescents with alcohol use disorders. J Subst Abuse Treat 2003; 25:293-295.
4. Emslie GJ, Weinberg WA, Kowatch RA, Hughes CW, Carmody T, Rintelman J. A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression. Arch Gen Psychiatry 1997; 54:1031-1037.
5. Emslie GJ, Heiligenstein HH, Wagner KD, Hoog SL, Ernest DE, Brown E, Nilsson M, Jacobson JG. Fluoxetine for acute treatment of depression in children and adolescents: a placebo-controlled, randomized clinical trial. J Am Acad Child Adol Psychiatry 2002; 41:1205-1215.
6. U.S. Food and Drug Administration (FDA). Antidepressant use in children, adolescents, and adults. www.fda.gov/cder/drug/antidepressants/default.htm, issued October 15, 2004.
7. American Psychiatric Association (APA). APA responds to FDA/s new warning on antidepressants. APA News Release No. 04-55, October 15, 2004.
8. American College on Neuropsychopharmacology (ACNP). Executive Summary: Preliminary report of the task force on SSRIs and suicidal behavior in youth. Issued January 21, 2004.
9. March J, Silva S, Petrycki S, Curry J, Wells K, Fairbank J, Burns B, Domino M, McNulty S. Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for adolescents with depression study (TADS) randomized controlled trial. JAMA; 2004; 292:807-820.
10. Emslie GJ, Rush AJ, Weinberg WA, Kowatch RA, Carmody T, Mayes TL. Fluoxetine in child and adolescent depression: acute and maintenance treatment. Depress Anxiety 1998; 7:32-39.
11. Cornelius JR, Bukstein OG, Birmaher B, Salloum IM, Lynch K, Pollock NK, Gershon S, Clark D. Fluoxetine in adolescents with major depression and an alcohol use disorder: An open-label trial. Addict Behav 2001; 26:735-739.
12. Cornelius JR, Walters, M, Wood DS, Bukstein OG, Kelly TM, Clark DB. Recruitment patterns for a treatment study of adolescents with comorbid AUD/MDD. Alcohol Clin Exper Res 2004; 28:113A.
13. Cornelius JR, Clark DB, Bukstein OG, Kelly TM, Salloum IM, Wood DS. Fluoxetine in adolescents with comorbid major depression and an alcohol use disorder: a 3-year follow-up study. Addict Behav (in press).
14. Deas D, Randall CL, Roberts JS, Anton RF. A double-blind, placebo-controlled trial of sertraline in depressed adolescent alcoholics: a pilot study. Human Psychopharmacol 2000; 15:461-469.
15. Riggs PD, Mikulich SK, Coffman LM, Crowley TJ. (1997). Fluoxetine in drug-dependent delinquents with major depression: an open trial. J Child Adol Psychopharmacol 1997; 7:87-95.
16. Cornelius JR, Salloum IM, Ehler JG, Jarrett PJ, Cornelius MD, Perel JM, Thase ME, Black A. Fluoxetine in depressed alcoholics: a double-blind, placebo-controlled trial. Arch Gen Psychiatry 1997; 54:700-705.
17. Cornelius JR, Salloum IM, Haskett RF, Daley DC, Cornelius MD, Thase ME, Perel JM. Fluoxetine versus placebo in depressed alcoholics: a 1-year follow-up study. Addict Behav 2000; 25:307-310.
18. Cornelius JR, Bukstein OG, Salloum IM, Kelly TM, Wood DS, Clark DB. Fluoxetine in depressed AUD adolescents: a one-year follow-up evaluation. J Child Adol Psychopharmacol 2004; 14:33-38.
19. Cornelius JR, Bukstein OG, Salloum IM, Kelly TM, Matta JK, Wood DS. Sexual behavior and drinking among treated teens with comorbid AUD/MDD. Alcohol Clin Exper Res 2004; 28:112A.
20. Cornelius JR, Bukstein OG, Birmaher B, Salloum IM, Kelly TM, Walters MC, Matta JK, Wood DS, Clark DB. Alcohol Clin Exper Res (In Press)
21. Thomas MA. Grad rate up, near median of similar schools. University of Pittsburgh University Times 2005; 37(11):1.
22. Weisner C, Ray GT, Mertens JR, Satre DD, Moore C. Short-term alcohol and drug treatment outcomes predict long-term outcome. Drug Alcohol Depend 2003; 71:281-294.
23. Cornelius JR, Maisto SA, Martin CS, Bukstein OG, Salloum IM, Daley DC, Wood DS, Clark DB. Major depression associated with earlier alcohol relapse in treated teens with AUD. Addict Behav 2004; 1035-1038.
24. Birmaher B, Arbelaez C, Brent D. Course and outcome of child and adolescent major depressive disorder. Child Adol Psychiatric Clin N Am 2002; 11:619-638.
25. Clark DB. The natural history of adolescent alcohol use disorders. Addiction 2004; 99:5-22.
26. Maisto SA, Martin CS, Pollock NK, Cornelius JR, Chung TA. Non-problem drinking outcomes in adolescents. Exper Clin Psychopharmacol 2002; 10:324- 331.
27. Cornelius JR, Salloum IM, Haskett RF, Ehler JG, Jarrett PJ, Thase ME, Perel JM. Fluoxetine vs. placebo for the marijuana use of depressed alcoholics. Addict Behav 1999; 24:111-114.
28. Cornelius JR. Fluoxetine for adolescents with comorbid major depression and an alcohol use disorder. Alcohol Clin Exper Res 2004; 28:176A.
29. Cornelius JR, Clark DB, Bukstein OG, Salloum IM. Chapter 16, Treatment of co-occurring alcohol, drug, and psychiatric disorders. In Recent Developments in Alcoholism, Volume 17, Alcohol Problems in Adolescents and Young Adults, edited by Marc Galanter, Published by Kluwer Academic/Plenum Publishers, New York, pages 349-365.
30. Cornelius JR, Salloum IM, Thase ME, Haskett RF, Daley DC, Jones-Barlock A, Upsher C, Perel JM. Fluoxetine vs. placebo in depressed alcoholic cocaine abusers. Psychopharmacol Bull, 1998; 34:117-121.
31. Cornelius JR, Perkins KA, Salloum IM, Thase ME, Moss HB. J Clin Psychopharmacol 1999; 19:183-184.